Outcomes of membranous and proliferative lupus nephritis – analysis of a single-centre cohort with more than 30 years of follow-up
Open Access
- 17 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 59 (11), 3314-3323
- https://doi.org/10.1093/rheumatology/keaa103
Abstract
To compare membranous lupus nephritis (MLN) and proliferative lupus nephritis (PLN) with respect to survival, demographic, clinical and laboratory characteristics; and to investigate predictors of renal and patient survival. Single-centre retrospective observational study. Patients with biopsy-proven PLN, MLN and mixed lupus nephritis were included. Groups were compared using appropriate statistical tests and survival was analysed through the Kaplan-Meier method. Cox regression analysis was performed to investigate predictors of renal and patient survival. A total of 187 patients with biopsy-proven lupus nephritis (135 with PLN, 38 with MLN and 14 with mixed LN) were followed for up to 42 years (median 12 years). There was a higher proportion of MLN amongst Afro-Caribbeans than amongst Caucasians (31% vs 15%, P = 0.010). Patients with MLN had significantly lower anti-dsDNA antibodies (P = 0.001) and higher C3 levels (P = 0.018) at diagnosis. Cumulative renal survival rates at 5, 10, 15 and 20 years were 91, 81, 75 and 66% for PLN and 100, 97, 92 and 84% for MLN, respectively (P = 0.028). Cumulative patient survival at 5, 10, 15 and 20 years was 94, 86, 80 and 76%, with no difference between PLN and MLN. Urinary protein-creatinine ratio above 42 mg/mmol and eGFR below 76 ml/min/1.73 m2, one year after the diagnosis of LN, were the strongest predictors of progression to end-stage renal disease. eGFR below 77 ml/min/1.73 m2, at one year, development of end-stage renal disease and Afro-Caribbean ethnicity were associated with higher mortality. Patients with MLN and PLN differ significantly regarding serological profiles and renal survival, suggesting different pathogenesis. Renal function at year one predicts renal and patient survival.Funding Information
- National Institute for Health Research University College
- London Hospitals Biomedical Research Centre
- LUPUS UK (1543411, 1579346)
- Medical Research Council (MR/P017371/1)
This publication has 41 references indexed in Scilit:
- Multiethnic lupus cohorts: What have they taught us?Reumatología Clínica, 2011
- Outcomes in Biopsy-Proven Lupus NephritisMedicine, 2010
- Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisionsLupus, 2010
- Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigmaNature Reviews Nephrology, 2009
- The prevalence and incidence of biopsy‐proven lupus nephritis in the UK: Evidence of an ethnic gradientArthritis & Rheumatism, 2006
- Mortality in systemic lupus erythematosusArthritis & Rheumatism, 2006
- An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year periodRheumatology, 2006
- Membranous lupus nephritisLupus, 2005
- Curso clínico de la nefropatía membranosa lúpica puraRevista médica de Chile, 2005
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997